“…Several studies have demonstrated the clinical utility of IPF in laboratory diagnosis of thrombocytopenia due to peripheral platelet destruction, particularly autoimmune thrombocytopenic purpura and thrombotic thrombocytopenic purpura [12,13]. The IPF was recently introduced as a novel diagnostic biomarker for infection and developing sepsis [14,15]. To our knowledge, however, no studies have evaluated the clinical value of IPF for coagulopathy or its prognostic value in patients with sepsis.…”